3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
2
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Brain Neoplasms
6
Glioblastoma
3
Oligodendroglioma
2
Neoplasm Metastasis
2
Glioma
2
Astrocytoma
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Interventions
Docetaxel
7
Radiotherapy
6
Filgrastim
6
Cisplatin
4
Peripheral Blood Stem Cell Transplantation
3
Chemotherapy, Adjuvant
3
Carboplatin
3
selpercatinib
2
sargramostim
2
Thiotepa
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Nivolumab
2
Gemcitabine
2
Etoposide
2
Drug Therapy
2
Doxorubicin
2
Capecitabine
2
Biopsy
2
Acupuncture Therapy
2
vocimagene amiretrorepvec
1
vandetanib
1
ulixertinib
1
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tanespimycin
1
spartalizumab
1
pentetreotide
1
pazopanib
1
oncogene protein E7, Human papillomavirus type 16
1
oblimersen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Quality of Life
×
CNS
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled